A detailed history of Eversept Partners, LP transactions in Bio Techne Corp stock. As of the latest transaction made, Eversept Partners, LP holds 607,687 shares of TECH stock, worth $43.5 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares
607,687
Previous 465,307 30.6%
Holding current value
$43.5 Million
Previous $35.9 Million 19.14%
% of portfolio
3.21%
Previous 3.51%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $9.39 Million - $11 Million
142,380 Added 30.6%
607,687 $42.8 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $4.2 Million - $6.21 Million
79,418 Added 20.58%
465,307 $35.9 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $2.92 Million - $3.87 Million
43,252 Added 12.62%
385,889 $26.3 Million
Q2 2023

Nov 08, 2023

BUY
$73.76 - $85.98 $11.4 Million - $13.2 Million
153,978 Added 81.62%
342,637 $28 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $11.4 Million - $13.2 Million
153,978 Added 81.62%
342,637 $28 Million
Q1 2023

Nov 08, 2023

BUY
$71.62 - $86.62 $12.3 Million - $14.9 Million
172,024 Added 1034.11%
188,659 $14 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $12.3 Million - $14.9 Million
172,024 Added 1034.11%
188,659 $14 Million
Q4 2022

Nov 08, 2023

BUY
$80.67 - $352.29 $1.26 Million - $5.49 Million
15,573 Added 1466.38%
16,635 $1.38 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $1.34 Million - $5.86 Million
16,635 New
16,635 $1.38 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $342,675 - $477,528
-1,062 Closed
0 $0
Q1 2022

Nov 08, 2023

SELL
$353.85 - $487.79 $121 Million - $167 Million
-341,575 Reduced 99.69%
1,062 $459,000
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $375,788 - $518,032
1,062 New
1,062 $460,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.81B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.